Synovial sarcoma accounts for nearly 10% of all soft tissue tumours, with an estimated 800-1,000 individuals receiving a diagnosis each year. This rare cancer has an incidence rate of approximately 0.177 per 100,000 people in the United States. Synovial Sarcoma Drug Pipeline Analysis Due to the